AIM Total Revenue vs Long Term Debt Analysis

0A4Y Stock

0.23 0.01 4.55%

AIM ImmunoTech financial indicator trend analysis is way more than just evaluating AIM ImmunoTech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AIM ImmunoTech is a good investment. Please check the relationship between AIM ImmunoTech Total Revenue and its Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.

Total Revenue vs Long Term Debt

Total Revenue vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AIM ImmunoTech Total Revenue account and Long Term Debt. At this time, the significance of the direction appears to have very week relationship.

The correlation between AIM ImmunoTech's Total Revenue and Long Term Debt is 0.25. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of AIM ImmunoTech, assuming nothing else is changed. The correlation between historical values of AIM ImmunoTech's Total Revenue and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of AIM ImmunoTech are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Total Revenue i.e., AIM ImmunoTech's Total Revenue and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.25

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Revenue

Total revenue comprises all receipts AIM ImmunoTech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Long Term Debt

Long-term debt is a debt that AIM ImmunoTech has held for over one year. Long-term debt appears on AIM ImmunoTech balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on AIM ImmunoTech balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from AIM ImmunoTech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AIM ImmunoTech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.Selling General Administrative is likely to drop to about 8 M in 2024

AIM ImmunoTech fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Short Term Investments	Capital Surpluse	Other Current Assets	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Other Liab	Net Tangible Assets	Accounts Payable	Long Term Debt	Net Receivables	Other Stockholder Equity	Short Term Debt
Total Assets		-0.78	1.0	-0.82	1.0	-0.7	1.0	-0.66	0.91	-0.63	-0.14	0.99	0.89	0.76	-0.88	0.02	-0.87	1.0	-0.95	0.7	0.83	-0.71	-0.63
Total Current Liabilities	-0.78		-0.79	0.62	-0.75	0.28	-0.79	0.2	-0.7	0.43	0.38	-0.78	-0.73	-0.74	0.65	-0.24	0.84	-0.77	0.77	-0.41	-0.51	0.41	0.43
Total Stockholder Equity	1.0	-0.79		-0.8	1.0	-0.7	1.0	-0.66	0.91	-0.62	-0.2	0.99	0.88	0.78	-0.86	-0.01	-0.86	0.99	-0.94	0.66	0.8	-0.67	-0.62
Retained Earnings	-0.82	0.62	-0.8		-0.83	0.52	-0.83	0.54	-0.76	0.28	-0.11	-0.83	-0.82	-0.55	0.9	-0.21	0.88	-0.83	0.9	-0.81	-0.87	0.87	0.28
Cash	1.0	-0.75	1.0	-0.83		-0.73	1.0	-0.7	0.92	-0.61	-0.14	0.99	0.89	0.78	-0.89	-0.02	-0.86	1.0	-0.94	0.7	0.83	-0.71	-0.61
Other Assets	-0.7	0.28	-0.7	0.52	-0.73		-0.69	0.87	-0.61	0.4	0.07	-0.64	-0.56	-0.57	0.51	0.35	0.41	-0.73	0.53	-0.43	-0.5	0.45	0.4
Cash And Short Term Investments	1.0	-0.79	1.0	-0.83	1.0	-0.69		-0.65	0.92	-0.61	-0.14	0.99	0.9	0.76	-0.89	0.04	-0.88	1.0	-0.96	0.71	0.83	-0.72	-0.61
Short Term Investments	-0.66	0.2	-0.66	0.54	-0.7	0.87	-0.65		-0.6	0.37	0.11	-0.65	-0.52	-0.65	0.59	0.54	0.32	-0.68	0.53	-0.37	-0.55	0.37	0.37
Capital Surpluse	0.91	-0.7	0.91	-0.76	0.92	-0.61	0.92	-0.6		-0.44	-0.12	0.91	0.98	0.79	-0.93	0.04	-0.86	0.92	-0.91	0.82	0.91	-0.75	-0.44
Other Current Assets	-0.63	0.43	-0.62	0.28	-0.61	0.4	-0.61	0.37	-0.44		-0.23	-0.64	-0.32	-0.23	0.43	-0.23	0.48	-0.6	0.57	-0.29	-0.37	0.34	1.0
Total Liab	-0.14	0.38	-0.2	-0.11	-0.14	0.07	-0.14	0.11	-0.12	-0.23		-0.11	-0.12	-0.59	-0.09	0.63	-0.07	-0.13	-0.05	0.37	0.19	-0.44	-0.23
Total Current Assets	0.99	-0.78	0.99	-0.83	0.99	-0.64	0.99	-0.65	0.91	-0.64	-0.11		0.88	0.75	-0.91	0.05	-0.88	0.99	-0.97	0.71	0.84	-0.72	-0.64
Intangible Assets	0.89	-0.73	0.88	-0.82	0.89	-0.56	0.9	-0.52	0.98	-0.32	-0.12	0.88		0.77	-0.94	0.11	-0.89	0.9	-0.91	0.86	0.92	-0.8	-0.32
Common Stock	0.76	-0.74	0.78	-0.55	0.78	-0.57	0.76	-0.65	0.79	-0.23	-0.59	0.75	0.77		-0.68	-0.37	-0.59	0.77	-0.66	0.36	0.55	-0.28	-0.23
Property Plant Equipment	-0.88	0.65	-0.86	0.9	-0.89	0.51	-0.89	0.59	-0.93	0.43	-0.09	-0.91	-0.94	-0.68		-0.17	0.9	-0.89	0.96	-0.88	-0.97	0.86	0.43
Short Long Term Debt Total	0.02	-0.24	-0.01	-0.21	-0.02	0.35	0.04	0.54	0.04	-0.23	0.63	0.05	0.11	-0.37	-0.17		-0.44	0.02	-0.25	0.38	0.19	-0.44	-0.23
Other Liab	-0.87	0.84	-0.86	0.88	-0.86	0.41	-0.88	0.32	-0.86	0.48	-0.07	-0.88	-0.89	-0.59	0.9	-0.44		-0.88	0.96	-0.82	-0.84	0.83	0.48
Net Tangible Assets	1.0	-0.77	0.99	-0.83	1.0	-0.73	1.0	-0.68	0.92	-0.6	-0.13	0.99	0.9	0.77	-0.89	0.02	-0.88		-0.95	0.72	0.83	-0.73	-0.6
Accounts Payable	-0.95	0.77	-0.94	0.9	-0.94	0.53	-0.96	0.53	-0.91	0.57	-0.05	-0.97	-0.91	-0.66	0.96	-0.25	0.96	-0.95		-0.83	-0.91	0.84	0.57
Long Term Debt	0.7	-0.41	0.66	-0.81	0.7	-0.43	0.71	-0.37	0.82	-0.29	0.37	0.71	0.86	0.36	-0.88	0.38	-0.82	0.72	-0.83		0.96	-0.98	-0.29
Net Receivables	0.83	-0.51	0.8	-0.87	0.83	-0.5	0.83	-0.55	0.91	-0.37	0.19	0.84	0.92	0.55	-0.97	0.19	-0.84	0.83	-0.91	0.96		-0.93	-0.37
Other Stockholder Equity	-0.71	0.41	-0.67	0.87	-0.71	0.45	-0.72	0.37	-0.75	0.34	-0.44	-0.72	-0.8	-0.28	0.86	-0.44	0.83	-0.73	0.84	-0.98	-0.93		0.34
Short Term Debt	-0.63	0.43	-0.62	0.28	-0.61	0.4	-0.61	0.37	-0.44	1.0	-0.23	-0.64	-0.32	-0.23	0.43	-0.23	0.48	-0.6	0.57	-0.29	-0.37	0.34

Click cells to compare fundamentals

AIM ImmunoTech Account Relationship Matchups

AIM ImmunoTech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.2M	13.8M	20.8M	64.6M	74.3M	78.0M
Total Current Liabilities	5.3M	1.1M	1.1M	673K	605.7K	575.4K
Total Stockholder Equity	8.7M	5.2M	13.4M	61.3M	70.5M	74.0M
Retained Earnings	(318.6M)	(327.6M)	(342.0M)	(361.1M)	(325.0M)	(341.2M)
Cash	1.4M	299K	1.5M	38.5M	44.3M	46.5M
Other Assets	1.4M	1.9M	748K	1.3M	1.2M	1.1M
Cash And Short Term Investments	2.1M	1.8M	8.8M	39.0M	44.9M	47.1M
Short Term Investments	695K	1.5M	7.3M	501K	576.2K	547.3K
Capital Surpluse	317.4M	323.7M	340.2M	402.5M	462.9M	374.0M
Total Liab	5.5M	8.7M	7.3M	3.3M	3.8M	6.2M
Total Current Assets	3.8M	10.4M	40.3M	50.2M	57.7M	60.6M
Intangible Assets	858K	912K	1.2M	1.5M	1.7M	1.2M
Common Stock	1K	10K	42K	48K	55.2K	29.0K
Property Plant Equipment	7.8M	7.3M	6.7M	4.2M	3.8M	5.9M
Other Liab	1.1M	57K	180K	35K	31.5K	29.9K
Net Tangible Assets	4.3M	11.5M	59.1M	54.2M	62.3M	65.4M
Accounts Payable	680K	472K	383K	198K	178.2K	169.3K
Net Receivables	1.1M	820K	1.1M	1.6M	1.9M	1.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for AIM Stock Analysis

When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AIM Total Revenue vs Long Term Debt Analysis

Total Revenue vs Long Term Debt

Total Revenue vs Long Term Debt Correlation Analysis

Correlation Coefficient

Total Revenue

Long Term Debt

AIM ImmunoTech fundamental ratios Correlations

AIM ImmunoTech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AIM ImmunoTech fundamental ratios Accounts

Also Currently Popular

Additional Tools for AIM Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Other Stockholder Equity	- 0.98	Long Term Debt
Net Receivables	- 0.97	Property Plant Equipment
Accounts Payable	- 0.97	Total Current Assets
Accounts Payable	- 0.96	Cash And Short Term Investments
Accounts Payable	- 0.95	Net Tangible Assets
Accounts Payable	- 0.95	Total Assets